DermEffects: Dr. Wei Jing Loo
1560 Hyde Park Road
London, ON N6H 5L5
Medical Inquiries: (519) 472-2929
Cosmetic Inquiries: (519) 472-8686
Fax: (519) 472-8484
Monday–Friday: 7 a.m.–3 p.m.

Research & Clinical Trials

Dr. Loo is an adjunct professor at the University of Western Ontario and is very familiar with the rigor needed to conduct research and clinical trials that produce valuable results.

Dr. Wei Jing Loo uses her expertise and extensive training to help advance the fields of medical and cosmetic dermatology through her London, Ontario, practice. Regulatory agencies such as Health Canada and the FDA in the United States require clinical research trials before approving new treatments, preventive procedures, or devices.

Dr. Loo is an adjunct professor at the University of Western Ontario and is very familiar with the rigor needed to conduct research and clinical trials that produce valuable results. She has published her work in many peer-reviewed journals and has presented her research at national and international meetings.

Dr. Loo is an adjunct professor at the University of Western Ontario and is very familiar with the rigor needed to conduct research and clinical trials that produce valuable results.

Dr. Loo and her staff follow strict protocols and regulations when conducting clinical research trials.

Patients interested in participating in a clinical trial, sometimes called clinical studies, can volunteer by contacting DermEffects. If you’re accepted to participate, you can also decide to withdraw at any time.

Other important information to know for patients who participate in clinical research trials include:

  • Your participation is voluntary.
  • All information about you remains confidential.
  • Before participating in a study, Dr. Loo or another member of the clinical research team will explain all the details about the study to patients, including any potential risks or benefits, and answer all questions.
  • Patients have as much time as necessary to decide if they want to participate.
  • Patients who decide to participate must sign a consent form. They will keep a copy of this consent form, which contains additional information about the clinical research trial.

An Elite Skincare Specialist

Dr. Loo is an experienced, board-certified dermatologist who established DermEffects with a vision of providing excellent cosmetic and medical skin care.

Meet Dr. Wei Jing Loo Request a Consultation

Every clinical research trial is submitted to an independent research ethics board for approval before the study can be performed.

If you’re interested in learning about current clinical research trials, please visit ResearchTrials.org.

Please note that a physician referral is required for all medical consultations and treatments. Medical consultations are a benefit of Ontario Health Insurance Plan (OHIP). Elective services offered at DermEffects are not covered by OHIP.

Active Clinical Trials

We are currently recruiting for the following studies:

Moderate to Severe Plaque Psoriasis Research (24 Weeks)

Adults aged 18 to 75 years (inclusive) with a diagnosis of plaque psoriasis for 24 weeks or more, may qualify for this study. Qualified participants must also have moderate to severe disease with psoriatic plaques covering 10% or more body surface area. Individuals with a diagnosis of non-plaque psoriasis or drug-induced psoriasis, are not qualified for this study.

Participants will receive investigational oral medication (active study drug) or placebo. Study medication and study-related assessments will be provided at no cost.

Study participation will last about 24 weeks and involve about 9 visits to the study centre.

Moderate to Severe Psoriasis Research Trial (24 Weeks)

Adults at least 18 years old and not more than 65 years of age with a clinical diagnosis of moderate to severe chronic plaque psoriasis with a disease duration of at least 6 months, may qualify to participate. Individuals must have 10% or more body surface area (BSA) affected by plaque psoriasis, and have no other skin disease which may interfere with assessment of chronic plaque psoriasis.

Participants will receive investigational oral medication (active study drug) or placebo. Study medication and study-related assessments will be provided at no cost.

Study participation will last about 24 weeks and involve about 8 visits to the study centre, plus a follow-up phone call.

Glabellar (Frown) Lines Research Trial (14 Weeks)

Adults at least 18 years old with moderate or severe Glabellar Lines (GL) at maximum frown, assessed by using the Facial Wrinkle Scale (FWS), may qualify for this clinical research trial. These wrinkles between the eyebrows are ones that develop from repeated facial expression. Qualified individuals must not have received treatment with any botulinum neurotoxin for aesthetic treatment within the last 6 months, and for therapeutic treatment within the last 12 months.

Participants will receive investigational medication (active study drug) or placebo via injection. Study medication and study-related care will be provided at no cost to you.

Study participation will last about 14 weeks and involve about 24 visits to the study centre.

Research Trial for Chronic Spontaneous Urticaria 2 (60 Week)

Individuals 18 years of age and older with Chronic Spontaneous Urticaria (CSU) lasting 6 months or more, may qualify to participate. Eligible participants must have the presence of itch and hives for 6 consecutive weeks or more prior to screening, despite the use of second generation H1-antihistamines. Documentation of hives within 3 months before randomization into the study, is also required.

Participants will receive an oral investigational medication (active study drug) or placebo.

Study medication and study-related assessments will be provided at no cost.

Study participation will last about 60 weeks and involve about 13 visits to the study center

Prurigo Nodularis Research Trial (52 Weeks)

Adults (male or female) aged 18 years to 80 years  with a clinical diagnosis of prurigo nodularis (PN) for at least 6 months, may qualify to participate. Individuals must have nodular lesions on the upper limbs, trunk, and/or lower limbs with at least 20 nodules on the entire body, distributed bilaterally (on both sides). Moderate to severe disease must be present, as well as severe pruritus (itch).

Participants will receive investigational medication (active study drug) or placebo, via injection. At Week 16 everyone will be investigational medication (active study drug)

Investigational medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Upcoming Trials

Moderate to Severe Atopic Dermatitis 28 weeks

Moderate to Severe Hidradenitis Suppurativa (HS) 24 weeks

Child-Adult Atopic Dermatitis Research Trial (8 Weeks)

Children and adults aged 6 years or older with a diagnosis of atopic dermatitis (AD), may qualify to participate. Individuals must have mild to moderate AD with involvement of 3% or more body surface area (BSA). A history of AD for at least 3 months (if 6-17 years of age) or 6 months (if 18+ years of age) is required along with stable disease for the past 4 weeks with no significant flares, before screening.

Participants will receive investigational topical medication (active study drug) or placebo, via a cream. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses will also be provided.

Study participation will last about 8 weeks and involve about 5 visits to the study centre.

Prurigo Nodularis Research Trial (52 Weeks)

Pamphlet for research study.

Adults (male or female) aged 18 years to 80 years  with a clinical diagnosis of prurigo nodularis (PN) for at least 6 months, may qualify to participate. Individuals must have nodular lesions on the upper limbs, trunk, and/or lower limbs with at least 20 nodules on the entire body, distributed bilaterally (on both sides). Moderate to severe disease must be present, as well as severe pruritus (itch).

Participants will receive investigational medication (active study drug) or placebo, via injection. At Week 16 everyone will be investigational medication (active study drug)

Investigational medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Observational Psoriasis Research Study

You may qualify if you take pills, injections, infusions, or are receiving light therapy for psoriasis. Participants must be 18 or older. If you qualify, you’ll have regular visits with psoriasis specialists. There is no cost to participate, and participants will receive reasonable compensation for travel or parking cost.

Participants will be asked to visit the study centre about 11 times over a 5 year period.

Email Tina Craig, Clincal Research Coordinator at DermEffects to register.